share_log

Bristol-Myers Squibb | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

施贵宝 | FWP:自由书写募资说明书

美股SEC公告 ·  02/15 15:03
Moomoo AI 已提取核心信息
On February 14, 2024, Bristol-Myers Squibb Company announced the pricing of a multi-tranche debt offering totaling $11.75 billion, with varying maturities ranging from 2026 to 2064. The offering includes Floating Rate Notes due 2026, and fixed-rate notes with maturities in 2026, 2027, 2029, 2031, 2034, 2044, 2054, and 2064, each with specified interest rates, reoffer prices, and yield to maturities. The Floating Rate Notes will bear interest at a rate reset quarterly based on Compounded SOFR plus a margin. The settlement date for the notes is scheduled for February 22, 2024. The issuer's ratings by Moody's and S&P are A2 (negative) and A (stable), respectively. The offering is made under a previously filed registration statement with the SEC, and the notes will be issued in a T+5 settlement cycle. The announcement...Show More
On February 14, 2024, Bristol-Myers Squibb Company announced the pricing of a multi-tranche debt offering totaling $11.75 billion, with varying maturities ranging from 2026 to 2064. The offering includes Floating Rate Notes due 2026, and fixed-rate notes with maturities in 2026, 2027, 2029, 2031, 2034, 2044, 2054, and 2064, each with specified interest rates, reoffer prices, and yield to maturities. The Floating Rate Notes will bear interest at a rate reset quarterly based on Compounded SOFR plus a margin. The settlement date for the notes is scheduled for February 22, 2024. The issuer's ratings by Moody's and S&P are A2 (negative) and A (stable), respectively. The offering is made under a previously filed registration statement with the SEC, and the notes will be issued in a T+5 settlement cycle. The announcement also includes detailed terms for each note tranche, such as principal amounts, interest payment dates, record dates, coupons, spread to benchmark treasury, and underwriting discounts. The joint lead managers and book-running managers for the transaction are Citigroup Global Markets Inc., BofA Securities, Inc., Wells Fargo Securities, LLC, and Mizuho Securities USA LLC, among others.
2024年2月14日,百时美施贵宝公司宣布了总额为117.5亿美元的多批债务发行的定价,期限从2026年到2064年不等。本次发行包括2026年到期的浮动利率票据,以及到期于2026年、2027年、2029年、2031年、2034年、2044年、2054年、2054年和2064年的固定利率票据,每张票据都有规定的利率、再要约价格和到期收益率。浮动利率票据将根据复合SOFR加上保证金按季度重置的利率计算利息。这些票据的结算日期定于2024年2月22日。穆迪和标准普尔对该发行人的评级分别为A2(负面)和A(稳定)。此次发行是根据先前向美国证券交易委员会提交的注册声明进行的,票据将在T+5结算周期内发行。该公告还包括每批票据的详细条款,例如本金、利息支付日期、记录日期、息票、基准国库利差和承保折扣。该交易的联席牵头经办人和账面管理人是花旗集团环球市场公司、美银证券有限公司、富国银行证券有限责任公司和瑞穗证券美国有限责任公司等。
2024年2月14日,百时美施贵宝公司宣布了总额为117.5亿美元的多批债务发行的定价,期限从2026年到2064年不等。本次发行包括2026年到期的浮动利率票据,以及到期于2026年、2027年、2029年、2031年、2034年、2044年、2054年、2054年和2064年的固定利率票据,每张票据都有规定的利率、再要约价格和到期收益率。浮动利率票据将根据复合SOFR加上保证金按季度重置的利率计算利息。这些票据的结算日期定于2024年2月22日。穆迪和标准普尔对该发行人的评级分别为A2(负面)和A(稳定)。此次发行是根据先前向美国证券交易委员会提交的注册声明进行的,票据将在T+5结算周期内发行。该公告还包括每批票据的详细条款,例如本金、利息支付日期、记录日期、息票、基准国库利差和承保折扣。该交易的联席牵头经办人和账面管理人是花旗集团环球市场公司、美银证券有限公司、富国银行证券有限责任公司和瑞穗证券美国有限责任公司等。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息